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400 Decreased bone mineral density in adolescents and young adults
with cystic ﬁbrosis: prevalence and risk factors
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France
Aims: To determine bone mineral density (BMD) status and potential risk factors
of demineralization in adolescents and young adults with cystic ﬁbrosis (CF).
Methods: Dual-energy X-ray absorptiometry (DEXA) was performed in a cohort
of 33 CF patients (17.1±4.2 years) to measure BMD at the lumbar spine. Various
clinical and biochemical parameters reﬂecting nutritional, respiratory, infectious
and metabolic status were obtained at DEXA time and retrospectively in the
prepubertal period (PPP). The data were analysed using univariate and multiple
linear regressions.
Results: The median BMD Z-score was −1.14 SD [min −3.64; max 1.44].
Eleven patients (33%) had osteopenia (−2SD<Z-score−1SD) and 8 (24%)
had osteoporosis (Z-score −2 SD). The Z-score value was signiﬁcantly related
to the patient height (expressed in SD) in the PPP (p< 0.01) and at DEXA
time (p< 0.001). Univariate linear regressions showed that Z-score value was
signiﬁcantly associated with parameters reﬂecting nutritional (caloric and calcium
intake, BMI) and infectious (precipitins against P. aeruginosa) status during the
PPP but not at the time of DEXA. Multiple linear regression (R2 = 0.37) conﬁrmed
the association between Z-score and precipitins against P. aeruginosa (p = 0.03,
b-coeff. = −1.08±0.47), BMI (p = 0.05, b-coeff. = 0.04±0.02) and caloric intake
(p = 0.05, b-coeff. = −0.29±0.14) in PPP, whereas none of them at DEXA time was
related to Z-score.
Conclusion: Decreased BMD is frequent (57%) among adolescents and young
adults with CF, and related to prepubertal infectious and nutritional parameters.
These results suggest that more effective strategies may be developed before puberty
to prevent the bone demineralization during adulthood.
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Previous studies suggest that nutritional status and muscular function in CF patients
worsen with disease progression, but how this deterioration is linked to the loss of
lung function is not fully understood. The aim of this study was to characterize
how progression of respiratory disease in CF patients impacts on nutritional status,
peripheral muscular strength and bulk, aerobic capacity, and weekly physical activity
(PA). We hypothesized that nutritional status and muscle function would follow a
biphasic pattern, with values remaining relatively stable early on and then dropping
when signiﬁcant airﬂow obstruction develops.
We tested this hypothesis in 28 (16 males) clinically stable adult CF patients (age:
29±7 yrs; FEV1: 56±25%pred; BMI: 20.2±3.0 kg/m2) and 17 (9 males) healthy
controls (HC) matched for age and gender. Average (±SD) values in patients and
HC were 374±114 vs 407±119N (NS) for isometric quadriceps strength (quadPT),
55±15 vs 60±13 cm2 (NS) for quadriceps cross-section (quadCSA), 28.1±6.8 vs
34.4±7.5ml·kg−1.min−1 (p< 0.01) for peak oxygen uptake (pVO2), and 9±12 vs
17.8±18.6 h·w−1 (NS) for weekly PA assessed by Kriska’s Modiﬁable Activity
Questionnaire. In CF patients, the best ﬁt between FEV1 and BMI, quadPT,
quadCSA, pVO2 and PA was obtained with linear correlations (r = 0.44−0.68,
p< 0.05). In both groups, BMI was linearly correlated with quadPT and quadCSA
(r = 0.52−0.67, p< 0.05). Furthermore, BMI was linearly correlated with PA in
CF patients (r = 0.62, p< 0.001). In conclusion, the deterioration of muscle function,
physical performance and nutritional status in CF patients parallels the loss of
pulmonary function.
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Cystic ﬁbrosis (CF) is a multisystemic life-threatening disorder with a dysfunction
of exocrine glands as the main feature. It is inherited as an autosomal recessive trait,
and therefore usually diagnosed early in infancy. Clinical features may signiﬁcantly
vary between patients, which could be the obstacle for early diagnosis of CF. Main
sites of involvement are pulmonary and gastrointestinal tracts, liver, pancreas and
sweat glands. Oral cavity is rather rarely involved. This may include lip enlargement
(relatively common), and bioﬁlm-induced enanthema of both free and attached
gingiva associated with mild xerostomia (relatively uncommon).
We present the case of a man 32 years old, who reported to the specialist of
periodontology and oral medicine due to chronic enlargement of a lower lip. Patient
history did not reveal any general disease, except “frequently repeated respiratory
infections”. As 10-days topical application of corticosteroid ointment did not affect
lip enlargement, we reffered the patient to his physician for further ivestigation.
Two weeks later we were informed that CF was diagnosed in this patient. It is
concluded that lip enlargement as a clinical feature of atypical CF should be kept
in mind during diagnostic process.
403 Estimating the age of common CFTR mutations in Brittany
(western France)
Y. Fichou1,2, E. Ge´nin3, C. Le Mare´chal1,4, M.P. Audre´zet1,2, V. Scotet1,
C. Fe´rec1,4. 1Inserm U613, Ge´ne´tique Mole´culaire et Ge´ne´tique Epide´miologique,
EFS – Re´gion Bretagne, Brest, France; 2Laboratoire de Ge´ne´tique Mole´culaire,
CHRU Morvan, Brest, France; 3Inserm U535, Ge´ne´tique Epide´miologique et
Structure des Populations Humaines, Hoˆpital Paul Brousse, Villejuif, France;
4Ge´ne´tique Somatique et Constitutionnelle, Universite´ de Bretagne Occidentale,
Brest, France
Cystic ﬁbrosis (CF) is the most common autosomal recessive disorder affecting
children in Caucasian population. CF is caused by mutations within the CF trans-
membrane conductance regulator (CFTR) gene (7q31.2), which encodes a 1,480
aminoacid cAMP-dependent chloride channel. To date, more than 1,500 mutations
and polymorphims within the CFTR gene have been reported. The p.F508del
mutation accounts for ~70% of the total mutated alleles and only four additional
mutations have a frequency >1% in the general population. However, disparities
exist between speciﬁc populations depending on their ethnical and/or geographical
origins. We used a simple likelihood-based method [Ge´nin et al., 2004] to estimate
the age of the most recent common ancestors carrying CFTR mutations that
are preferentially observed in Brittany (western France). The occurence of CF is
particularly high in this region as compared with other areas: ~1/2,600 in Brittany
vs ~1/3,500 in the Caucasian population, with a typical spectrum of mutations:
p.W846X2, c.1078delT, p.G551D and p.F508del mutations, as well as the p.I1027T
polymorphism, a variant that is found in cis with the p.F508del mutation. By using
our method, we were able to estimate the number of generations since each of the
variants appeared in Brittany. This work actually provides historical perspectives in
the ﬁeld of understanding population migrations.
